BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 29
• 30

• Drug Development

  Merck & Co., Inc. Halts Studies On Single-Dose HIV Treatment, Isentress After Phase III Trial

  November 29, 2010

   · 

  3 min read
• FDA

  FUJIFILM Receives FDA Clearance for Synapse(R) 3D

  November 29, 2010

   · 

  3 min read
• Policy

  Merck KGaA Says FDA Extends Review of Multiple Sclerosis Pill, Caldribine in Setback for Novartis AG

  November 29, 2010

   · 

  1 min read
• Business

  EndoStim Licenses Novel Device Developed by Arizona State University Researcher for Neurostimulation Treatment of Diseases Affecting Hundreds of Millions from Arizona Technology Enterprises

  November 29, 2010

   · 

  4 min read
• Drug Development

  FDA Questions Benefit of Using GlaxoSmithKline’s Avodart to Cut Prostate Cancer Risk

  November 29, 2010

   · 

  1 min read
• Stent Maker, REVA Medical Inc. Pumps Up Its Prospects With $85M Raising

  November 29, 2010

   · 

  1 min read
• Biotech Bay

  Intarcia Therapeutics, Inc. Bets It Will Shake Up Diabetes Treatment With Implantable Device

  November 29, 2010

   · 

  1 min read
• Business

  GlaxoSmithKline to Buy $129.4M in Theravance, Inc. Stock

  November 29, 2010

   · 

  1 min read
• Biotech Beach

  Apricus Biosciences Announces New NexACT(R) Transbuccal Delivery Data Published in the International Journal of Pharmaceutics

  November 29, 2010

   · 

  1 min read
• Deals

  3SBio Inc. Acquires Worldwide Rights to Pegsiticase From EnzymeRx for $6.25 Million

  November 29, 2010

   · 

  4 min read